Dogwood Therapeutics, Stock Today
| DWTX Stock | 6.33 0.50 7.32% |
PerformanceOK
| Odds Of DistressQuite High
|
Dogwood Therapeutics, is trading at 6.33 as of the 21st of March 2025; that is 7.32% down since the beginning of the trading day. The stock's open price was 6.83. Dogwood Therapeutics, has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Dogwood Therapeutics, symbol was changed from VIRI on 9th of October 2024. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
IPO Date 17th of December 2020 | Category Healthcare |
Dogwood Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 1.33 M outstanding shares of which 38.19 K shares are currently shorted by private and institutional investors with about 0.01 trading days to cover. More on Dogwood Therapeutics,
Moving against Dogwood Stock
Dogwood Stock Highlights
| Older Symbol | VIRI |
| Chairman CEO | Gregory Duncan |
| Thematic Idea | Pharmaceutical Products (View all Themes) |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
| Average Analyst Recommendation | |
Dogwood Therapeutics, (DWTX) is traded on NASDAQ Exchange in USA. It is located in 44 Milton Avenue, Alpharetta, GA, United States, 30009 and employs 5 people. Dogwood Therapeutics, was previously known as VIRI Old and was traded on NASDAQ Exchange under the symbol VIRI. Dogwood Therapeutics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.17 M. Dogwood Therapeutics, conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 1.33 M outstanding shares of which 38.19 K shares are currently shorted by private and institutional investors with about 0.01 trading days to cover.
Dogwood Therapeutics, generates negative cash flow from operations
Check Dogwood Therapeutics, Probability Of Bankruptcy
Ownership AllocationDogwood Therapeutics, retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Dogwood Ownership Details
Dogwood Therapeutics, Historical Income Statement
Dogwood Stock Against Markets
Dogwood Therapeutics, Corporate Executives
Elected by the shareholders, the Dogwood Therapeutics,'s board of directors comprises two types of representatives: Dogwood Therapeutics, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dogwood. The board's role is to monitor Dogwood Therapeutics,'s management team and ensure that shareholders' interests are well served. Dogwood Therapeutics,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dogwood Therapeutics,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| William MD | Founder Board | Profile |
Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.